Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02846402
Other study ID # 16-0885
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2016
Est. completion date June 2017

Study information

Verified date May 2018
Source Harvard School of Public Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

HSPOT is a cluster-randomized trial designed to determine whether HIV self-tests are acceptable and improve HIV testing rates and HIV status knowledge among female sex workers in Kampala, Uganda. This study will determine whether directly giving participants an HIV self-test or giving them a coupon to collect a test at a drug store or clinic improves outcomes compared to standard of care.


Description:

Although Uganda has a generalized HIV epidemic, with approximately 7.4% of adults aged 15 to 49 living with HIV, the epidemic remains even more highly concentrated in key populations, including female sex workers (FSW). A particular concern for FSW is access to healthcare services, including HIV testing services. FSW face significant barriers to accessing healthcare. In other settings, evidence has suggested that stigma is a significant barrier to FSW seeking HIV testing. It is likely that similar mechanisms exist in Uganda. Evidence from Uganda has indicated that complex multilevel factors, such as stigmatization and harassment, contribute to vulnerability among FSW. User-controlled HIV prevention interventions that lead to empowerment of FSW may therefore be a powerful way to address the HIV epidemic in this key population.

Oral HIV self-testing consists of an oral swab kit that allows individuals to test for HIV in the privacy of their own homes whenever they want. The ease of use of HIV self-testing, that it can be done at any time, and that is completely private may make it an attractive alternative to currently-available HIV testing mechanisms for FSW in Uganda. HIV self-testing has generally been shown to be acceptable in a variety of populations, however evidence related to its uptake and acceptability remain sparse, especially among key populations and in Sub-Saharan Africa. This research will provide rigorous evidence of the uptake and efficacy of HIV self-testing for this population.

HSPOT was designed to determine whether either direct distribution of HIV self-test kits via peer educators or distribution of HIV self-tests via coupons that participants can use to collect kits at collection points such as drug stores or health posts leads to better coverage of HIV testing and better awareness of HIV status. HSPOT is a cluster-randomized trial in which peer educators recruit a small group of FSW participants, and the peer educator group is randomized to one of three study arms: 1) direct distribution of test kits, 2) fixed distribution of test kits, or 3) referral to standard of care HIV testing. The primary outcome is HIV testing in the past month measured at one and four months after the first peer educator visit (when the test kits or coupons are distributed in the intervention arms).


Recruitment information / eligibility

Status Completed
Enrollment 960
Est. completion date June 2017
Est. primary completion date May 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older on the enrollment visit date

- Reports exchanging sex (vaginal, anal, and/or oral) for money or goods at least once in the past month

- Self-reported HIV negative status and no recent (<3 months) HIV testing OR self-reported HIV unknown status

- Member of the hot spot where recruited for at least one month AND plans on remaining in the area for the next 4 months

- Have never used an oral HIVST kit

- Willing to participate in peer education sessions on a monthly basis over the 4-month study period and to participate in study assessments

- Of sound mind and not under influence of drugs or coercion

Exclusion Criteria:

- Less than 18 years of age on the enrollment date

- Has not exchanged any form of sex in the past one month

- Self-reported to be living with HIV

- Self-reported HIV negative status and reports testing within the last 3 months

- Planning to move out of geographic area within 4 months

- Concurrently participating in another HIV prevention study

- Meets criteria but does not wish to participate

- Not willing or able to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Oral HIV Self-Testing
The Oral HIV Self-Test is an in-home test that uses an oral swab to collect samples of oral mucosa that is used to detect the presence of HIV antibodies. The test is read after 20 minutes by the user. The test can be done by an individual at any time and place of the user's choosing. The test is read visually.

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
Harvard School of Public Health International Initiative for Impact Evaluation, International Research Consortium, Uganda Health Marketing Group

Outcome

Type Measure Description Time frame Safety issue
Other Linkage to HIV care and confirmatory testing One month from first intervention visit
Other Linkage to HIV care and confirmatory testing Four months from first intervention visit
Other HIV risk perception and beliefs about acquiring HIV One month from first intervention visit
Other HIV risk perception and beliefs about acquiring HIV Four months from first intervention visit
Other HIV disclosure with sexual partners One month from first intervention visit
Other HIV disclosure with sexual partners Four months from first intervention visit
Other Condom use with commercial sexual partners since last visit One month from first intervention visit
Other Condom use with commercial sexual partners since last visit Four months from first intervention visit
Other Condom use with non-commercial sexual partners since last visit One month from first intervention visit
Other Condom use with non-commercial sexual partners since last visit Four months from first intervention visit
Other Average number of commercial sexual partners One month from first intervention visit
Other Average number of commercial sexual partners Four months from first intervention visit
Other Average number of non-commercial sexual partners One month from first intervention visit
Other Average number of non-commercial sexual partners Four months from first intervention visit
Other Intimate partner violence, including sexual, physical, or verbal One month from first intervention visit
Other Intimate partner violence, including sexual, physical, or verbal Four months from first intervention visit
Other HIV fatalism One month from first intervention visit
Other HIV fatalism Four months from first intervention visit
Other Self-reported self-efficacy as measured by the General Self Efficacy Scale One month from first intervention visit
Other Self-reported self-efficacy as measured by the General Self Efficacy Scale Four months from first intervention visit
Other Female sex worker empowerment as measured by Beattie et al 2014 One month from first intervention visit
Other Female sex worker empowerment as measured by Beattie et al 2014 Four months from first intervention visit
Other Pre-exposure prophylaxis preferences One month from first intervention visit
Primary HIV testing in the previous month One month from first intervention visit
Primary HIV testing in the previous month Four months from first intervention visit
Secondary Knowledge of own HIV status Four months from first intervention visit
Secondary HIV self-test kit use in the two intervention arms One month from first intervention visit
Secondary HIV self-test kit use in the two intervention arms Four months from first intervention visit
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02135419 - Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions Phase 3
Active, not recruiting NCT02663856 - My Smart Age With HIV: Smartphone Self-assessment of Frailty
Completed NCT02659306 - Metformin Immunotherapy in HIV Infection Phase 1
Completed NCT02663869 - Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
Completed NCT02921516 - Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Completed NCT02564341 - Targeting Effective Analgesia in Clinics for HIV - Intervention N/A
Active, not recruiting NCT02302950 - A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas N/A
Completed NCT01830595 - Lactoferrin Treatment in HIV Patients Phase 2
Terminated NCT01902186 - Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir Phase 4
Completed NCT02269605 - Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment Phase 1
Completed NCT01852942 - Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV Phase 2
Terminated NCT02109224 - Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection Phase 1
Completed NCT02525146 - Birmingham Access to Care Study N/A
Completed NCT02527135 - Text Messaging to Improve HIV Testing Among Young Women in Kenya N/A
Completed NCT02118168 - Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002 N/A
Completed NCT01946217 - Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials N/A
Active, not recruiting NCT02602418 - Neural Correlates of Working Memory Training for HIV Patients N/A
Completed NCT01702974 - Immune Reconstitution in HIV Disease (IREHIV) Phase 2
Completed NCT01805427 - Antiretroviral Therapy and Extreme Weight N/A